Docsity
Docsity

Prepara tus exámenes
Prepara tus exámenes

Prepara tus exámenes y mejora tus resultados gracias a la gran cantidad de recursos disponibles en Docsity


Consigue puntos base para descargar
Consigue puntos base para descargar

Gana puntos ayudando a otros estudiantes o consíguelos activando un Plan Premium


Orientación Universidad
Orientación Universidad

resumen del cancer de colon, Apuntes de Endocrinología

resumen del cancer de color, sus patologias y como se da

Tipo: Apuntes

2024/2025

Subido el 20/03/2025

daniela-duque-26
daniela-duque-26 🇲🇽

3 documentos

1 / 3

Toggle sidebar

Esta página no es visible en la vista previa

¡No te pierdas las partes importantes!

bg1
My mother has a large traditional family, with six brothers and nine sisters. Most of
them I have only ever met a handful of times, usually at weddings or funerals.
Despite this, my mother stays in close contact with all of them by phone as often as
she can.
This past year, one of her closer sisters came for a visit. She stayed for about a
month but wasn’t quite feeling herself. After her stay, she returned home to visit her
local clinic, and they sent her off for a more thorough examination at a hospital. It was
then that they found a tumor in her colon that had spread to her liver and lungs. My
mother was heartbroken to learn that her sister was diagnosed with late-stage,
metastatic colon cancer.
The last part of the gastrointestinal tract, the $large intestine$includes both the colon
(about six feet long) and the rectum (the final eight inches or so). This long and
muscular tube is an essential part of human digestion. It’s where reabsorption of
water and important nutrients occurs before removal of toxic waste products.
A great number of gastrointestinal cancer cases are mischaracterized as either colon
or rectal cancer, and despite important differences between cancers of colon and
rectal tissues, the all-encompassing term$colorectal cancer is commonly used for
both.
One of the leading causes of cancer mortality worldwide, colorectal cancer is
estimated to have taken the lives of more than 50,000 people in the United States in
2019.
Development and symptoms
The$development$of cancer in the large intestine is generally a slow process. Initially
developing as a small and benign polyp (usually adenoma) from the glandular cells
lining the colon, it over decades can grow to invade the wall of the colon or rectum.
There, cancer cells penetrate blood vessels or the lymphatic system and travel to
distant sites of the body (typically the liver and lungs).
Although early colorectal cancer is usually asymptomatic, as the polyp grows into a
larger tumor it can implicate the passage of matter through the intestine and disrupt
other normal intestinal functions to cause bleeding. Blood in the stool, although not
always a sign of cancer, is a first indicator of the need for further examination. Other
symptoms that present include but are not limited to abdominal discomfort,
decreased appetite, weight loss, and other irregular changes to bowel movements.
Risk factors
So what puts us at risk for developing this disease?
The traditional “Western lifestyle” has been implicated in the development and
progression of colorectal cancer. Habits such as smoking, heavy alcohol intake,
pf3

Vista previa parcial del texto

¡Descarga resumen del cancer de colon y más Apuntes en PDF de Endocrinología solo en Docsity!

My mother has a large traditional family, with six brothers and nine sisters. Most of them I have only ever met a handful of times, usually at weddings or funerals. Despite this, my mother stays in close contact with all of them by phone as often as she can. This past year, one of her closer sisters came for a visit. She stayed for about a month but wasn’t quite feeling herself. After her stay, she returned home to visit her local clinic, and they sent her off for a more thorough examination at a hospital. It was then that they found a tumor in her colon that had spread to her liver and lungs. My mother was heartbroken to learn that her sister was diagnosed with late-stage, metastatic colon cancer. The last part of the gastrointestinal tract, the large intestine includes both the colon (about six feet long) and the rectum (the final eight inches or so). This long and muscular tube is an essential part of human digestion. It’s where reabsorption of water and important nutrients occurs before removal of toxic waste products. A great number of gastrointestinal cancer cases are mischaracterized as either colon or rectal cancer, and despite important differences between cancers of colon and rectal tissues, the all-encompassing term colorectal cancer is commonly used for both. One of the leading causes of cancer mortality worldwide, colorectal cancer is estimated to have taken the lives of more than 50,000 people in the United States in

Development and symptoms The development of cancer in the large intestine is generally a slow process. Initially developing as a small and benign polyp (usually adenoma) from the glandular cells lining the colon, it over decades can grow to invade the wall of the colon or rectum. There, cancer cells penetrate blood vessels or the lymphatic system and travel to distant sites of the body (typically the liver and lungs). Although early colorectal cancer is usually asymptomatic, as the polyp grows into a larger tumor it can implicate the passage of matter through the intestine and disrupt other normal intestinal functions to cause bleeding. Blood in the stool, although not always a sign of cancer, is a first indicator of the need for further examination. Other symptoms that present include but are not limited to abdominal discomfort, decreased appetite, weight loss, and other irregular changes to bowel movements. Risk factors So what puts us at risk for developing this disease? The traditional “Western lifestyle” has been implicated in the development and progression of colorectal cancer. Habits such as smoking, heavy alcohol intake,

consumption of processed meats and physical inactivity have been shown to contribute to colorectal cancer development over time. Stronger risk factors for development include family history of the disease (with smaller percentages of inherited genetic factors), obesity, diabetes and inflammatory bowel disease. The slow development of this cancer means that it is rarely detected in young people. Those between 65 and 75 years of age most affected. Alarmingly, however, there has been a recent small surge of cases and mortality in individuals between 20 and 49 years old. This trend might be related the sedentary lifestyle and poorly balanced diet of many Americans during the past several decades. A promising future The good news for all of us is that improvements in screening and detection have allowed for both prevention and better management in cases of colorectal cancer. The American Cancer Society recommends that people of average risk begin screenings at age 45. Colonoscopy, done every 10 years, is the gold-standard screening method, but less invasive at-home stool tests also are available. If a benign polyp is detected during a colonoscopy, surgical removal during the procedure often is successful, but it depends on the size of the tumor and its developmental stage. A malignant colorectal polyp is not a death sentence in 2020. Physicians now have advanced knowledge about how best to treat each patient based on a wealth of genetic data gathered over decades using hundreds of thousands of patient samples. The transition of the field from using strictly kinetic poison chemotherapy regimens to the inclusion of biologics tailored and directed at specific factors driving the cancer has greatly improved patient survival and quality of life. For people like my aunt, this is great news. As an early-career researcher focusing my research on anticancer pharmacology, I am keenly interested to see our understanding of the disease progress and what the future holds for patients. Research in ASBMB journals Giving good old aspirin a new look: Over several decades, researchers have investigated the anticancer effects of many medications not traditionally used as cancer therapies. In a 2018 paper in the Journal of Lipid Research, researchers in Germany wrote about their investigations into the lipid profiles of healthy colon tissue from individuals without or with aspirin and/or statin treatment. They suggested that their findings support the hypothesis that such agents can inhibit the tumorigenesis of colorectal cancer by modifying lipid levels in the intestinal tissue.